|
JPS61263917A
|
|
Cerebral function normalizing agent
|
|
JPS60243074A
|
|
4-phenylphthalazine derivative
|
|
JPS61167614A
|
|
Steroic-containing ointment
|
|
JPS6136273A
|
|
2-phenylalkyl-4(3h)-quinazolinone derivative
|
|
JPS60218377A
|
|
4-phenylphthalazine derivative and ameliorant of circulation containing same as active constituent
|
|
JPS60148564A
|
|
Drug automatic administration apparatus
|
|
JPS60104011A
|
|
Coating of solid drug
|
|
JPS6058973A
|
|
Gamma-butyrolactone derivative and immunological regulating agent containing the same as active constituent
|
|
JPS59144769A
|
|
2-phenylalkylthio-3-alkyl-5,6-polymethylene-4(3h)- pyrimidinone derivative
|
|
JPS5944365A
|
|
2-phenylalkylthio-4(3h)-quinazolinone derivative
|
|
JPS5916878A
|
|
Production of 2,4-dihydroxy-3-acetylquinoline
|
|
JPS58144391A
|
|
6-alkylpyranoquinolin-4-one-2-carboxylic acid derivative and its pharmacologically permissible salt
|
|
JPS5857394A
|
|
Novel glucoside of carboxylic acid derivative having antiphlogistic activity
|
|
JPS5855454A
|
|
Suloctidil-cyclodextrin clathrate compound
|
|
JPS5829800A
|
|
Clathrate compound of spironolactone-cyclodextrin
|
|
JPS58999A
|
|
Proscillaridin-cyclodextrin clathrate
|
|
JPS57167974A
|
|
Preparation of 4-phenylphthalazine derivative
|
|
JPS57143302A
|
|
Clucide corticoid-cyclodextrin clathrate compound and anti-inflammatory external agent containing the same as active constituent
|
|
JPS57131771A
|
|
Novel pyrimidine derivative
|
|
JPS5793965A
|
|
Novel trimethoxyquinazoline derivative
|
